Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)

v3.3.0.814
Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands
 3 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Net sales $ 112,381,000 $ 108,477,000
Cost of sales 36,990,000 35,411,000
Gross margin 75,391,000 73,066,000
Operating expenses:    
Selling, general and administrative 33,040,000 28,701,000
Research and development 11,322,000 9,149,000
Total operating expenses 44,362,000 37,850,000
Operating income 31,028,000 35,216,000
Other (expense) income 818,000 (618,000)
Earnings before income taxes 31,847,000 34,598,000
Income taxes 9,139,000 10,691,000
Net earnings 22,707,000 23,907,000
Other comprehensive (loss) income:    
Foreign currency translation adjustments (12,896,000) (9,103,000)
Unrealized losses on available-for-sale investments, net of tax of ($3,752) and ($100), respectively (10,125,000) (8,488,000)
Other comprehensive loss (23,021,000) (17,591,000)
Comprehensive income (loss) $ (314,000) $ 6,316,000
Earnings per share:    
Basic (in dollars per share) $ 0.61 $ 0.65
Diluted (in dollars per share) 0.61 0.64
Cash dividends per common share: (in dollars per share) $ 0.32 $ 0.31
Weighted average common shares outstanding:    
Basic (in shares) 37,169 37,007
Diluted (in shares) 37,315 37,148